OpenVSafe by OpenVAERS
Search V-safe

CPN-10950-40621

5 vaccinations 8 coded responses 23 check-ins 8 free-text entries 1 call case
Sex
Male
Age at first dose
36-40
ZIP prefix
141 / NY
Registered
2021-04-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-23
    Registered in v-safe
  3. 2021-04-23
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-23
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  7. 2021-04-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  8. 2021-04-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  9. 2021-05-08
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  10. 2021-05-17
    Survey response — day 21, dose 2
    MedDRA: Asthenia, Dyspnoea, Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Tiredness, weakness, shortness of breath. All believed to be due to an unrelated infection.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-21
    Health check-in — day 28, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-06-05
    Survey response — day 42, dose 2
    MedDRA: Headache, Lethargy, Somnolence — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Frequent headache and increased lethargy/drowsiness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-07-23
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  14. 2021-11-15
    Dose 3 — Pfizer-BioNTech
  15. 2022-04-07
    Dose 4 — Pfizer-BioNTech
  16. 2022-04-23
    Health check-in — day 14, dose 4
    Feeling: Poor
    Adult check-in
  17. 2022-04-23
    Survey response — 12 months, dose 2
    MedDRA: Asthma, Back injury, Dyspnoea, Pre-existing disease, Skin infection — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Back injury, increased difficulty breathing due to more frequent asthma triggers, frequent dermal infections.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-04-28
    Survey response — day 21, dose 4
    MedDRA: Anosmia, COVID-19, Cough, Dyspnoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Loss of smell, shortness of breath, cough, probable COVID-19 infection
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-05-23
    Survey response — day 42, dose 4
    MedDRA: COVID-19, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Contracted COVID-19 with longterm effects, exacerbated by underlying health conditions.
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-07-07
    Survey response — 3 months, dose 4
    MedDRA: Skin infection — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Multiple skin infections.
    MedDRA releases: 2024-11 · check-in free text available
  21. 2022-09-19
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  22. 2022-09-30
    Health check-in — day 7, dose 5
    Feeling: Fair · Headache
    Adult check-in
  23. 2022-10-03
    Health check-in — day 14, dose 5
    Feeling: Fair
    Adult check-in
  24. 2022-10-10
    Health check-in — day 21, dose 5
    Feeling: Fair
    Adult check-in
  25. 2022-10-17
    Survey response — day 28, dose 5
    MedDRA: Migraine, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Migraines have been more frequent.
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-10-24
    Health check-in — day 35, dose 5
    Feeling: Fair
    Adult check-in
  27. 2022-11-02
    Health check-in — day 42, dose 5
    Feeling: Poor
    Adult check-in
  28. 2022-12-19
    Survey response — 3 months, dose 5
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Contracted COVID-19.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-12-19
    Report sent to call center — 3 months, dose 5
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  30. 2022-12-20
  31. 2022-12-22
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  32. 2023-03-20
    Health check-in — 6 months, dose 5
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech
22021-04-23Pfizer-BioNTech
32021-11-15Pfizer-BioNTech No
42022-04-07Pfizer-BioNTech No
52022-09-19Pfizer-BioNTech Flu

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 8 — day 21, dose 2

2021-05-17

Symptoms: Tiredness, weakness, shortness of breath. All believed to be due to an unrelated infection.

Release 8 — day 42, dose 2

2021-06-05

Symptoms: Frequent headache and increased lethargy/drowsiness.

Release 11 — 12 months, dose 2

2022-04-23

Symptoms: Back injury, increased difficulty breathing due to more frequent asthma triggers, frequent dermal infections.

Release 11 — day 21, dose 4

2022-04-28

Symptoms: Loss of smell, shortness of breath, cough, probable COVID-19 infection

Release 11 — day 42, dose 4

2022-05-23

Symptoms: Contracted COVID-19 with longterm effects, exacerbated by underlying health conditions.

Release 12 — 3 months, dose 4

2022-07-07

Symptoms: Multiple skin infections.

Release 12 — day 28, dose 5

2022-10-17

Symptoms: Migraines have been more frequent.

Release 12 — 3 months, dose 5

2022-12-19

Symptoms: Contracted COVID-19.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnosmia · · ✓
SDAsthenia ✓ ✓ ✓
SDAsthma · · ✓
SDBack injury · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDyspnoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDLethargy ✓ ✓ ✓
SDMigraine · · ✓
SDPre-existing disease · · ✓
SDSkin infection · · ✓
SDSomnolence ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release